Skip to content
Abierto

Award notice

PREVENT IDIQ MATO RFP

75N91024D00005

National Institutes of Health, NIH NCI. Research and Development in Biotechnology (except Nanobiotechnology).

Awarded

University of Oklahoma

$149,995,000.00 on the award notice, January 24, 2024, contract 75N91024D00005

Description

As published on SAM.gov.

PREVENT EFFICACY Pool: This contract supports the PREVENT Cancer Preclinical Drug Development Program, which provides a structured approach to drug and vaccine development, from discovery to the clinic. This contract is a part of a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) pool to procure services related to Preclinical Efficacy and Intermediate Endpoint Biomarkers, which is also referred to as the Efficacy Pool.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
GY8NMUZQXVS7
CAGE
4B862
Vendor location
Oklahoma City, OK
Contract
75N91024D00005
Obligated
$0.00, potential $149,995,000
Actions
6 between January 24, 2024 and July 9, 2026
Competition
Full and Open Competition, 9 offers received
Set-aside reported
No Set Aside Used.
Described as
Preclinical Efficacy & Intermediate Endpoint Biomarkers IDIQ Contract in Support of the Prevent Cancer Preclinical Drug Development Program
Match
award number 75N91024D00005 equals the contract number; same awarding office 75N910 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. January 29, 2024

    Award notice, originally solicitation

    Awarded to UNIVERSITY OF OKLAHOMA Oklahoma City for $149,995,000. SAM.gov, notice 6fe40644401a45eca74e10f015c711ad

  2. January 31, 2024

    Award notice

    Awarded to UNIVERSITY OF OKLAHOMA Oklahoma City for $149,995,000. SAM.gov, notice 828a2cf3019d4988acb882feeeb9dd6f

Points of contact